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Abstract
Background: Since there is no effective treatment or vaccine against the congenital cytomegalovirus (cCMV)
infection, knowledge and awareness of medical doctor’s (MDs) especially family doctors are essential for preventive
strategies and it also seems to be usually ignored by healthcare providers. Aim of this study was to investigate
awareness of MDs about cCMV infection in Iran.
Methods: A single page questionnaire was randomly distributed among 450 MDs including general practitioners,
pediatricians, gynecologists, internal and other medical specialists concerning of their knowledge in clinical presentation,
diagnosis, prevention, prognosis, epidemiology, transmission, and management of cCMV infection. All statistical analyses
were performed using SPSS version 16.
Results: More than half of questionnaire recipients refused to take part in any of the questionnaire items. The most of
the respondents were agreed for newborn CMV screening tests and mandatory CMV test for women trying to get
pregnant, which, are not routinely tested. The knowledge of general practitioners about cCMV was less than usual. The
field of expertise had a profound effect in this survey, but age and gender did not.
Conclusions: Our results indicated that the knowledge of cCMV infection, especially among family doctors contains
several gaps. Urgent action is required to improve family doctor’s knowledge of CMV infection. Surveys to evaluate CMV
awareness among MDs, healthcare professionals and women of childbearing age are proposed.
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Background
Human cytomegalovirus (CMV) is an widespread virus
and establishes lifelong latency following primary infec-
tion. Congenital CMV is one of the serious public health
problems and the cause of the most common non-
hereditary childhood hearing loss, but largely remains
unrecognized in infants due to asymptomatic or nonspe-
cific symptoms. Congenital CMV infection also is one of
the common causes of neurodevelopmental delay, hear-
ing loss and vision loss in developing countries. There
are no symptoms at birth in about 90% of infected in-
fants in an early period of life but about 10% of infants
with cCMV infection will develop serious disorders,
such as hearing loss, mental retardation, jaundice, sei-
zures and microcephaly which have many side effects for
lifetime. cCMV accounts for 20% to 25% of cases of
sensorineural hearing loss (SNHL) and 30 to 35% will
suffer of central nervous system (CNS) sequelae in de-
veloped countries. Unfortunately, for many parts of the
world the maternal and birth CMV prevalence data are
lacking, but certainly, the prevalence is higher in devel-
oping countries [1–7].
Since there is no effective vaccine against the cCMV
infection yet, simple hygienic precautions remain the
only successful strategy to prevent of cCMV infection.
The rate of vertical transmission of CMV infection from
mother to fetus is dependent on the time of mother’s in-
fection [8–10]. Previous studies suggest that there is a
limited awareness or knowledge about cCMV and pre-
vention strategies among women who have educated by
Family Practice Physicians and also it has been shown
that delivery of prevention counseling to the pregnant
women by healthcare providers were highly effective at
raising awareness among pregnant women [11, 12].
Therefore, a successful preventive strategy depends on
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awareness of congenital CMV among MDs. There are
insufficient data about the awareness and knowledge of
cCMV infection among medical doctors and health care
workers in developing countries. In order to investigate
the clinician’s knowledge and awareness of cCMV, the
responsiveness survey was carried out concerning clin-
ical presentation, diagnosis, prevention, prognosis, epi-
demiology, transmission, and managemen of cCMV in
MDs for the first time in Iran.
Methods
This cross-sectional study was conducted in the North
of Iran. A single page questionnaire on cCMV infection
was randomly distributed among 450 family medical
doctors to determine knowledge of cCMV. The ques-
tionnaire was anonymous and consisted of four parts, in-
cluding demographic data, awareness, knowledge, and
attitude about cCMV infection.
Demographic data regarding age, sex, educational
level, professional field and work place were also asked.
Finally, all questionnaires were collected and most were
considered complete or almost complete when all im-
portant items were accepted to calculate. Incomplete
and inconsistent responses to the questionnaire were ex-
cluded from the survey. In order to measure or deter-
mine the validity and reliability of the questionnaire
using a pilot test, judgments of seven professors and ex-
pert in the scientific field of virology, clinical epidemi-
ology and medical statistics were reviewed and analyzed.
The questionnaire summary is given in Tables 1 and 2 as
well as in Additional file 1.
All statistical analyses were performed using SPSS ver-
sion 16 (SPSSInc., Chicago, IL, USA), comparisons be-
tween different groups of respondents were made using
SPSS Chi-Square test with the significance level set at (P
value < 0.05).
Results
The questionnaire was completed by 198 respondents.
Among them, 70.7% (140) were general practitioner
(family doctors) and 29.3% (58) were medical special-
ists. In medical specialists group, 9.1% [13] were re-
sponsible in the care of mothers and children and
20.2% (40) were as other specialist. The mean age of
responders was 33.77 years. Of them, 34.7% were fe-
male and 62.6% were male, 82.9% of respondents
were working in hospitals, 12.6% in administration of-
fices, and 4.5% in health centers.
All related medical specialists, except one (6%), cor-
rectly identified modes of CMV transmission (True an-
swers: blood contact and sexual intercourse,
breastfeeding, kissing and changing diapers), (false an-
swers: air conduction, direct skin, all items) and in the
general practitioners and other medical specialists
groups 86% and 90% gave true answer, respectively. No
statistically significant differences were found between
the groups (p value = 0.556).
In general practitioners group, 52% gave true answers
about the symptoms in immune competent adults (True
answers: without symptoms, elevated liver enzymes),
(False answers: cardiac problems, visual problems, all
items), and 83% and 73% of related and unrelated
Table 1 Summery of questionnaire and responses in three different groups
Knowledge concerning General practitioners Related medical specialties Unrelated medical specialties Total P value
Transmission route True 86% (121) 94% (17) 90% (36) 87.88% (174) 0.556
False 14% (19) 6% (1) 10% (4) 12.12% (24)
Symptoms in immune Competent adults 52. % (73)
48% (67)
83% (15)
17% (3)
73% (29)
28% (11)
59.09% (117)
40.91% (81)
0.006
Signs and symptoms in the 59% (82) 94% (17) 53% (21) 60.61% (120) 0.007
Neonatal period 41% (58) 6% (1) 48% (19) 39.39% (78)
Long-term effects 59. % (83) 94% (17) 68% (27) 64.14% (127) 0.012
Sampling location 41% (57) 6% (1) 33% (13) 35.86% (71)
69% (97) 83% (15) 73% (29) 71.21% (141) 0.455
Confirmation test 31% (43) 17% (3) 28% (11) 28.79% (57)
25% (35) 22% (4) 45% (18) 28.79% (57) 0.039
Prevalence of symptomatic 75% (105) 78% (14) 55% (22) 71.21% (141)
34% (47) 72% (13) 50% (20) 40.40% (80) 0.003
Infection in infants 66% (93) 28% (5) 50% (20) 59.60% (118)
Proper sampling time 60% (84) 89% (16) 68% (27) 64.14% (127) 0.049
40% (56) 11% (2) 33% (13) 35.86% (71)
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medical specialists knew the correct answer, respectively
(p value = 0.006).
Research findings showed that growth restriction,
microcephaly, and seizures were known as a neonatal
symptom of cCMV by 94% of the related medical spe-
cialists, while only 53% of the unrelated medical special-
ists and 59% of the general practitioners knew the
correct answer. About 39.3% of participants considered
cardiac and renal diseases as cCMV infection wrongly.
There were statistically significant differences between
groups (p value = 0.007).
According to the findings, 94% of related medical spe-
cialists indicated correctly long-term effects of CMV
congenital infection (True answers: hearing loss and vis-
ual problems, seizures, cognitive delay and dyspraxia),
(false answers: risk of malignancy, no long-term effect,
do not know) and 68 and 59% of unrelated medical spe-
cialists and general practitioners identified correct an-
swer, respectively (p value = 0.003).
In general practitioners group, 69% gave true an-
swers about proper specimen (True answers: saliva,
urine, blood or amniotic fluid), (false answers: CSF,
all items) and 83 and 73% of related and unrelated
medical specialists knew the correct answer, respect-
ively (p value = 0.455).
Nucleic acid testing (NAT) is the most sensitive
method for the detection and confirmation of the
cCMV infection and only 25, 22 and 45% of general
practitioners, related and unrelated medical specialists
gave true answers, respectively (p value = 0.039).
The prevalence of symptomatic cCMV infection is
less than 20% in infected infants. According to the
findings, 72% of related medical specialists, 50 and
72% of unrelated medical specialists and general
practitioners identified correct answer, respectively.
There were significant differences between groups (p
value = 0.003).
The gold time for the quick and reliable diagnosis of
cCMV infection in newborns is the detection of the
virus within the first 2–3 weeks of life. In this study,
89% of related medical specialists, 68 and 60% of unre-
lated medical specialists and general practitioners identi-
fied correct answer, respectively (p value = 0.049).
However, gender issue and age did not have necessar-
ily to be related to knowledge but the fields of expertise
of participants did. As expected, most of medical spe-
cialists, especially, doctors involved in the care of
mothers and children could identify answers correctly
and awareness increased with higher level of education
(P value< 0.05).
In attitude questions (Table 2 and Additional file 1),
more than half of the respondents (63.6%) were strongly
or somewhat agreed for newborn screening tests to de-
tect genetic and metabolic disorders and hearing loss
and also 72.2% of respondents were strongly or some-
what agreed to development mandatory CMV test for
women trying to get pregnant. Only 4.5% of respondents
were certainly agreed and 19.7% were somewhat agreed,
that there is a prenatal diagnostic test for prognosis.
Most doctors (84.9%) believed that infants with
established cCMV infection at birth should be at
long-term follow-up to improve their physiological
deficiencies. 14.6% of respondents were strongly
agreed and 43.4% were agreed, that there is effective
preventive interventions (vaccine and efficient thera-
peutic treatments) for CMV infection. Only 5.6% of
respondents were certainly agreed that congenital
CMV infection is hereditary diseases.
As in usual CMV is shedding in urine or saliva of con-
genitally infected infants in very high quantities the
present study showed 33.3% of doctors were agreed and
6.6% were certainly agreed to measure virus titer at
regular intervals in infected infants.
The Table 2 explains some of the attitudes of the
respondents.
Discussion
Congenital CMV is kept going by the lack of awareness,
inaccessibility of an effective vaccine and efficient thera-
peutic treatments. However, the infection in pregnant
women and subsequently, congenital infection can be
markedly reduced with the use of knowledge about the
nature of the virus and its ways of transmission. Poor
training of health professionals is one of the main obsta-
cles to reduce congenital CMV infection. The result of
this study showed that awareness of congenital CMV
Table 2 Attitude questions and responses
Questions Mandatory
CMV test
Prenatal
diagnostic
test
Preventive
interventions
Following
infected
infants
Newborn
screening
tests
Apparent
disease in
next child
Following
virus
shedding
Answers
No idea 10.6% (21) 56.6% (111) 26.3% (52) 6.1% (12) 17.7% (35) 30.3% (60) 32.3% (64)
Certainly Disagree 5.6% (11) 9.09% (18) 4% (8) 2% (4) 5.6% (11) 31.3% (62) 10.1% (20)
Disagree 11.6% (23) 10.61% (21) 11.6% (23) 7.1% (14) 13.1% (26) 16.7% (33) 14.6% (29)
Agree 37.9% (75) 19.7% (39) 43.4% (86) 46% (91) 39.9% (79) 16.2% (32) 33.3% (66)
Certainly Agree 34.3% (68) 4.5% (9) 14.6% (29) 38.9% (77) 23.7% (47) 5.6% (11) 9.6% (19)
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infection among doctors was not in high quality at least
on some aspects, and requires improvement.
Report in France showed that 46 and 23% of med-
ical doctors did not recognize the transmission route
and symptoms of CMV infection in newborns, re-
spectively [14] while in Netherland only half of the
respondent’s knew symptoms in newborns [15] .In
comparison to above studies our survey demonstrated
that doctors were more aware and possess optimal
knowledge however, knowledge of CMV infection
among doctors in the North of Iran contained some
gaps, including attitudes towards preventive methods,
prevalence, and paraclinical information.
Our results showed nearly half of the medical doctors
knew wrongly, about application of effective prophylactic
drug treatments during pregnancy. CMV hyperimmune
globulin in pregnant women may prevent some congeni-
tal infection, but safety and efficacy of this treatment
and antiviral drugs have not been established and are
not routinely used [16, 17] .Until now, no effective inter-
vention is designed to cope with the cCMV infection.
Therefore, medical doctors must routinely counsel pa-
tients about CMV preventive methods and behavioral
interventions before pregnancy. In developing countries,
many of women in reproductive age are CMV seroposi-
tive [18] .A common source of CMV transmission to a
pregnant woman is via close contact with infected body
fluids (urine, saliva), frequently from young children, or
from household contacts. During viral reactivation/re-
infection or primary infection in pregnant women CMC
can be transmitted to the fetus. A method of preventing
cCMV is through hygienic practices, therefore, develop-
ing educational projects to promote effective hygiene is
very important [13] .Health care professionals can play a
critical role in disseminating information about prevent-
ive methods of c CMV infection to the women of child-
bearing age. Giving hygiene information to high-risk
women in childbearing age may be highly effective in
preventing CMV infection [19] .In the French survey,
about 20% of the respondents (44% in medical doctors)
knew there is available treatment during pregnancy
while it was 34.6% in Netherlands (55.3% in pediatrics
and 27.8% in obstetrics and gynecologists) as it was 58%
in our survey [14, 15] .It seems designing strategies for
changing the doctor’s attitudes towards preventive
methods is necessary.
Congenital CMV infection is more common than
many metabolic and endocrine disorders in infants.
Less than 20% of cCMV infections in children de-
velop disabilities. The universal newborn screening
(blood, urine and saliva specimens) would be improve
language and developmental outcomes through early
intervention, but costs and harms must be considered
[20, 21] .In this study, more than half of the doctors
were somewhat or certainly agree to newborns
screening program. Some of the European countries
routinely screen the majority of pregnant women
serologically for CMV without the recommendations
or guidelines of any governmental agency [22]
.Screening is not diagnostic; rather, it identifies indi-
viduals who should be referred for confirmatory diag-
nostic test. A positive screening result requires a
subsequent diagnostic evaluation. Accurate method
for diagnosis of CMV infection, such as a low avidity
anti-CMV IgG antibodies and nucleic acid test are
very expensive in our country and some women who
decided to get pregnant might oppose mandatory
CMV test and considered the potential costs of
screening. However, Cahill AG and colleagues showed
the universal screening for primary maternal cyto-
megalovirus infection is cost-effective [23] then,
healthcare professionals must provide counsel of
women in reproductive age about CMV screening. It
is necessary to consider whether voluntary tests with
informed decision would be more appropriate than
mandatory test.
In developing countries, follow-up of infected infants
is not performed because of financial costs. However,
more than half of the doctors have a positive attitude to-
wards establishment of these kinds of programs as soon
as possible.
The most significant limitation of the present study
was a very low response rate to the questionnaires.
Since respondents may do not care enough or re-
spondents who felt unsure about their knowledge of
CMV infection could refuse to respond to the ques-
tionnaire, it might imply that the true knowledge con-
cerning congenital CMV infection is even poorer than
reported. Large-scale surveys could be a good solu-
tions to solve this problem.
The knowledge of cCMV infection, especially
among general practitioners in North of Iran has
some gaps. In this study, medical doctors seem to
have low level of knowledge on the cCMV infection,
symptoms in healthy adults and know less about pre-
ventive interventions as well as less information about
the paraclinical aspects. This leads to poor manage-
ment of children with cCMV infection.
Conclusions
In developing countries conducting surveys to evaluate
CMV awareness among medical doctors, healthcare pro-
fessionals, and women of childbearing age are necessary.
Successful programs and methods to prevent, diagnose
or reduce the cCMV infection will require global aware-
ness among clinicians, pregnant women, medical and
non-medical staff for early detection and intervention
for preventive strategies and reducing clinical outcomes.
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CMV: Cytomegalovirus
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